Results 181 to 190 of about 1,022,396 (355)

Bioprinted Constructs in the Regulatory Landscape: Current State and Future Perspectives

open access: yesAdvanced Materials, EarlyView.
Bioprinting has rapidly emerged as a transformative technology in biomedical research, offering unprecedented potential to replicate complex tissues. Despite its promise, clinical translation remains limited due to regulatory hurdles. This review explores global regulatory frameworks, comparing approaches in the EU, U.S., China, and Australia, and ...
Francesca Perin   +6 more
wiley   +1 more source

The Role of a Bioengineered Artificial Kidney in Renal Failure [PDF]

open access: green, 2001
William H. Fissell   +4 more
openalex   +1 more source

Sacrificial Biofabrication for Vascularization: Concept, Materials, Technologies, and Applications

open access: yesAdvanced Materials, EarlyView.
Vasculature is indispensable for tissue viability in regenerative medicine. The sacrificial biofabrication enables precise fabrication of vascular channels by using temporary templates that are subsequently removed. This review defines the concept and delves into sacrificial materials, surrounding materials, fabrication technologies, and biomedical ...
Jiezhong Shi   +7 more
wiley   +1 more source

Elucidating Mechanisms of Hypomorphic WDR19-Related Kidney Failure. [PDF]

open access: yesKidney Int Rep
Shlomovitz O   +10 more
europepmc   +1 more source

EVIDENCE THAT EARLY ACUTE RENAL FAILURE MAY BE MEDIATED BY CD3- CD16+ CELLS IN A KIDNEY GRAFT RECIPIENT WITH LARGE GRANULAR LYMPHOCYTE PROLIFERATION

open access: bronze, 1992
Gilles Blancho   +9 more
openalex   +1 more source

Kidney failure after treatment with 90Y-DOTATOC [PDF]

open access: green, 2001
Tilmann Schumacher   +3 more
openalex   +1 more source

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

open access: yesAdvanced Materials, EarlyView.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy